Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. Scope of the Report: This report focuses on the Procalcitonin (CAS 56645-65-9) in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application. Market Segment by Manufacturers, this report covers Thermo Fisher Roche Diagnostics bioMerieux HyTest BBI Solutions? ProSpec Wondfo Ningbo Medicalsystem Biotechnology Wuhan Easy Diagnosis Biomedicine Snibe Vazyme Biotech Getein Biotech Hotgen Biotech Lumigenex Nanjing Norman Biological Technology Shanghai Medicine'nest Pharmaceutical Kitgen Beijing KeyGen Beijing Apis Market Segment by Countries, covering China Japan Korea Taiwan Southeast Asia India Australia Market Segment by Type, covers Procalcitonin Antigen Procalcitonin Antibody Market Segment by Applications, can be divided into Medical Industry Scientific Research There are 19 Chapters to deeply display the Asia-Pacific Procalcitonin (CAS 56645-65-9) market. Chapter 1, to describe Procalcitonin (CAS 56645-65-9) Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Procalcitonin (CAS 56645-65-9), with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Procalcitonin (CAS 56645-65-9), for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application; Chapter 14, Procalcitonin (CAS 56645-65-9) market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 17, to describe sales channel, distributors, traders, dealers etc. Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Procalcitonin (CAS 56645-65-9) Introduction 1.2 Market Analysis by Type 1.2.1 Procalcitonin Antigen 1.2.2 Procalcitonin Antibody 1.3 Market Analysis by Applications 1.3.1 Medical Industry 1.3.2 Scientific Research 1.4 Market Analysis by Countries 1.4.1 China Status and Prospect (2012-2022)
